Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/57823
Title: Expression levels and clinical values of miR-195, miR-424, miR-10b, miR-103a-3p, and miR-542-3p in vasculo-Behçet's disease
Authors: Kaymaz, S.
Demiray, A.
Karasu, U.
Çobankara, V.
Tan, S.
Keywords: Behçet's disease
microRNA-195
real-time quantitative PCR
serum
anticoagulant agent
colchicine
immunosuppressive agent
interferon
microRNA
microRNA 103a 3p
microRNA 10b
microRNA 195
microRNA 424
microRNA 542 3p
unclassified drug
adult
aged
Article
Behcet disease
Behcet Disease Current Activity Form
Behcet Syndrome Activity Scale
clinical feature
correlation analysis
cross-sectional study
demographics
disease activity
disease activity score
disease duration
gene expression level
human
major clinical study
patient coding
patient selection
real time polymerase chain reaction
RNA blood level
Turk (people)
vascular disease
Publisher: Greek Rheumatology Society and Professional Association of Rheumatologists
Abstract: Objective: MicroRNAs (miRNAs) are involved in a range of pathological and biological processes. Vascular involvement is an important complication associated with morbidity and mortality in Behçet's disease (BD). In this study, we aimed to evaluate the expression levels of miR-195, miR-424, miR- 10b, miR-103a-3p, and miR-542-3p in Turkish patients with BD, and their possible association with vascular involvement and clinical activity. Methods: This cross-sectional study included 61 BD patients and 25 age- and sex-matched healthy individuals. The patients were categorised into two groups based on the presence or absence of vascular involvement. Demographic data, disease duration, disease activity, and medical treatments were recorded. Disease activity was evaluated using the Behçet's Disease Current Activity Form (BDCAF) and the Behçet's Syndrome Activity Scale (BSAS). The expression levels of miRNAs were measured using real-time quantitative polymerase chain reaction (RT-qPCR). Results: The comparison of the clinical features of BD patients with and without vascular involvement revealed no significant difference. However, the expression levels of miR-195, miR-424, miR-10b, miR-103a-3p, and miR-542-3p were significantly higher in BD patients than in healthy controls (p<0.001, p<0.001, p=0.010, p<0.01, p=0.039, respectively). Moreover, the expression level of miR-195 was significantly higher in vasculo-Behçet patients than in the other groups (p=0.0318). However, no significant association was found between the expression levels of miR-195 and clinical activity. Conclusion: Our study results indicated elevated serum levels of miR-195 in BD patients, which may be associated with vascular involvement. Therefore, miR-195 could potentially serve as a biomarker for the diagnosis and monitoring of vasculo-Behçet's disease. © (2024), (Greek Rheumatology Society and Professional Association of Rheumatologists). All Rights Reserved.
URI: https://doi.org/10.31138/mjr.030623.elc
https://hdl.handle.net/11499/57823
ISSN: 2459-3516
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu

Show full item record



CORE Recommender

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.